Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Martin Website

Maureen P. Martin, M.D.

Portait Photo of Maureen Martin
Laboratory of Experimental Immunology
HLA Typing Section
Staff Scientist (Contr)
Center for Cancer Research
National Cancer Institute
Bldg. 560, Rm 21-76
P.O. Box B
Frederick, MD 21702-1201
Phone:  
301-846-5318
Fax:  
Fax Number not listed
E-Mail:  
mamartin@mail.nih.gov

Biography

Dr. Martin obtained her M.D. at the University of the West Indies, Jamaica in 1982 and completed a residency in Pathology in 1989. She was a Visiting Research Fellow in the Laboratory of Viral Carcinogenesis, NCI-Frederick from 1990-1995. Dr. Martin is currently a Senior Scientist in the HLA Immunogenetics Laboratory of Dr. Mary Carrington, Laboratory of Experimental Immunology at the NCI-Frederick.
Her research interests involve studies of host genetic effects on complex human diseases including infectious diseases, autoimmune diseases and cancer. Her focus is on genes known to participate in innate and acquired immunity, primarily the killer Immunoglobulin-like Receptor (KIR) genes and related loci.

Research

Research Projects:

1. Determine the genetic effects of HLA and KIR variants on disease.
Given the importance of KIR-mediated regulation of natural killer (NK) cell activity, their specificity for HLA class I allotypes, and their extensive genomic diversity, our efforts are geared towards characterizing the effects of KIR gene variation in resistance and susceptibility to diseases.

2. Characterize the molecular genetic properties of the KIR gene cluster.
A greater understanding of the evolutionary and molecular genetic characteristics of the KIR gene cluster is also a main objective. This is especially important for genetic loci that consist of multiple homologues that share functional activity such as the KIR genes because it provides a significant aid in identifying the actual disease locus amongst multiple possibilities. Thus, we aim to determine levels of LD between KIR genes and alleles using segregation analysis in families and population based studies, and characterize the organization and frequency of recombinant KIR haplotypes.

This page was last updated on 3/31/2014.